147 related articles for article (PubMed ID: 29336465)
1. Breast cancer stem-like cells are sensitized to tamoxifen induction of self-renewal inhibition with enforced Let-7c dependent on Wnt blocking.
Sun X; Xu C; Xiao G; Meng J; Wang J; Tang SC; Qin S; Du N; Li G; Ren H; Liu D
Int J Mol Med; 2018 Apr; 41(4):1967-1975. PubMed ID: 29336465
[TBL] [Abstract][Full Text] [Related]
2. Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells.
Sun X; Xu C; Tang SC; Wang J; Wang H; Wang P; Du N; Qin S; Li G; Xu S; Tao Z; Liu D; Ren H
Cancer Gene Ther; 2016 Apr; 23(4):83-9. PubMed ID: 26987290
[TBL] [Abstract][Full Text] [Related]
3. Nano Let‑7b sensitization of eliminating esophageal cancer stem‑like cells is dependent on blockade of Wnt activation of symmetric division.
Pang Y; Liu J; Li X; Zhang Y; Zhang B; Zhang J; Du N; Xu C; Liang R; Ren H; Tang SC; Sun X
Int J Oncol; 2017 Oct; 51(4):1077-1088. PubMed ID: 28902370
[TBL] [Abstract][Full Text] [Related]
4. FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4.
McClements L; Annett S; Yakkundi A; O'Rourke M; Valentine A; Moustafa N; Alqudah A; Simões BM; Furlong F; Short A; McIntosh SA; McCarthy HO; Clarke RB; Robson T
BMC Cancer; 2019 Apr; 19(1):351. PubMed ID: 30975104
[TBL] [Abstract][Full Text] [Related]
5. MiR-146a promotes the asymmetric division and inhibits the self-renewal ability of breast cancer stem-like cells via indirect upregulation of Let-7.
Liang R; Li Y; Wang M; Tang SC; Xiao G; Sun X; Li G; Du N; Liu D; Ren H
Cell Cycle; 2018; 17(12):1445-1456. PubMed ID: 29954239
[TBL] [Abstract][Full Text] [Related]
6. H19 regulation of oestrogen induction of symmetric division is achieved by antagonizing Let-7c in breast cancer stem-like cells.
Wang M; Li Y; Xiao GD; Zheng XQ; Wang JC; Xu CW; Qin S; Ren H; Tang SC; Sun X
Cell Prolif; 2019 Jan; 52(1):e12534. PubMed ID: 30338598
[TBL] [Abstract][Full Text] [Related]
7. Let‑7 miRNAs sensitize breast cancer stem cells to radiation‑induced repression through inhibition of the cyclin D1/Akt1/Wnt1 signaling pathway.
Sun H; Ding C; Zhang H; Gao J
Mol Med Rep; 2016 Oct; 14(4):3285-92. PubMed ID: 27574028
[TBL] [Abstract][Full Text] [Related]
8. The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.
Loh YN; Hedditch EL; Baker LA; Jary E; Ward RL; Ford CE
BMC Cancer; 2013 Apr; 13():174. PubMed ID: 23547709
[TBL] [Abstract][Full Text] [Related]
9. Monobenzyltin Complex C1 Induces Apoptosis in MCF-7 Breast Cancer Cells through the Intrinsic Signaling Pathway and through the Targeting of MCF-7-Derived Breast Cancer Stem Cells via the Wnt/β-Catenin Signaling Pathway.
Fani S; Dehghan F; Karimian H; Mun Lo K; Ebrahimi Nigjeh S; Swee Keong Y; Soori R; May Chow K; Kamalidehghan B; Mohd Ali H; Mohd Hashim N
PLoS One; 2016; 11(8):e0160836. PubMed ID: 27529753
[TBL] [Abstract][Full Text] [Related]
10. IL-33 facilitates endocrine resistance of breast cancer by inducing cancer stem cell properties.
Hu H; Sun J; Wang C; Bu X; Liu X; Mao Y; Wang H
Biochem Biophys Res Commun; 2017 Apr; 485(3):643-650. PubMed ID: 28216163
[TBL] [Abstract][Full Text] [Related]
11. Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway.
Jin B; Wang W; Meng XX; Du G; Li J; Zhang SZ; Zhou BH; Fu ZH
BMC Cancer; 2016 Nov; 16(1):863. PubMed ID: 27821157
[TBL] [Abstract][Full Text] [Related]
12. iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity.
Diaz Bessone MI; Simón-Gracia L; Scodeller P; Ramirez MLA; Lago Huvelle MA; Soler-Illia GJAA; Simian M
J Nanobiotechnology; 2019 Dec; 17(1):120. PubMed ID: 31812165
[TBL] [Abstract][Full Text] [Related]
13. miR-484 suppresses endocrine therapy-resistant cells by inhibiting KLF4-induced cancer stem cells in estrogen receptor-positive cancers.
Wei Y; Li H; Qu Q
Breast Cancer; 2021 Jan; 28(1):175-186. PubMed ID: 32865695
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
15. Sox2 promotes tamoxifen resistance in breast cancer cells.
Piva M; Domenici G; Iriondo O; Rábano M; Simões BM; Comaills V; Barredo I; López-Ruiz JA; Zabalza I; Kypta R; Vivanco Md
EMBO Mol Med; 2014 Jan; 6(1):66-79. PubMed ID: 24178749
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of breast cancer stem-like cells by a triterpenoid, ursolic acid, via activation of Wnt antagonist, sFRP4 and suppression of miRNA-499a-5p.
Mandal S; Gamit N; Varier L; Dharmarajan A; Warrier S
Life Sci; 2021 Jan; 265():118854. PubMed ID: 33278391
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin‑3‑gallate inhibits self‑renewal ability of lung cancer stem‑like cells through inhibition of CLOCK.
Jiang P; Xu C; Zhang P; Ren J; Mageed F; Wu X; Chen L; Zeb F; Feng Q; Li S
Int J Mol Med; 2020 Dec; 46(6):2216-2224. PubMed ID: 33125096
[TBL] [Abstract][Full Text] [Related]
18. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen-resistant breast cancer cells possess cancer stem-like cell properties.
Liu H; Zhang HW; Sun XF; Guo XH; He YN; Cui SD; Fan QX
Chin Med J (Engl); 2013 Aug; 126(16):3030-4. PubMed ID: 23981606
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen suppresses brain metastasis of estrogen receptor-deficient breast cancer by skewing microglia polarization and enhancing their immune functions.
Wu SY; Sharma S; Wu K; Tyagi A; Zhao D; Deshpande RP; Watabe K
Breast Cancer Res; 2021 Mar; 23(1):35. PubMed ID: 33736709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
